Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

CME Group thrives on market volatility with innovative derivatives, global growth, and strong financials, offering stability, ...

Shares of CME Group Inc. Cl A CME rallied 1.66% to $272.36 Tuesday, on what proved to be an all-around great trading session ...

What Happened: Gerdes's decision to sell 4,000 shares of CME Group was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the sale is $1,060,441 ...

DGRO boasts a low expense ratio, strong liquidity, and a healthy dividend yield. See why I think the fund is a buy.

UBS analyst Alex Kramm maintained a Buy rating on CME Group (CME – Research Report) yesterday and set a price target of $305.00. The company’s ...

Analysts have set 12-month price targets for CME Group, revealing an average target of $266.18, a high estimate of $305.00, ...

CME Group Inc. has reported all-time record revenue, adjusted operating income, adjusted net income, and adjusted earnings ...